Burt Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-100
Closed -$9K – 109
2020
Q4
$9K Buy
+100
New +$7.97K ﹤0.01% 284

Other funds holding ARKG

Burt Wealth Advisors's ARKG Position: Q1 2021 in Review

Burt Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 100 shares — an estimated $9K sold.

Burt Wealth Advisors first reported a position in ARKG in Q4 2020 and held it in 1 quarter. The position peaked at $9K in Q4 2020. 508 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

  • Burt Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
  • Burt Wealth Advisors sold 100 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $9K.
  • Burt Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 1 quarter.
  • Burt Wealth Advisors's ARK Genomic Revolution ETF position peaked at $9K in Q4 2020.
  • 508 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on Burt Wealth Advisors's 13F filing for Q1 2021, filed 15 Apr 2021.